How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Environmental and Sustainability · Forecast 2027–2033
Environmental Legionella Pneumophila Testing Market
- By Testing Method: Culture Method, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Enzyme-Linked Immunosorbent Assay (ELISA), Direct Fluorescent Antibody (DFA)
- By Sample Type: Water Samples, Air Samples, Biofilm Samples, Swab Samples
- By End-User: Healthcare Facilities, Commercial Buildings, Industrial Facilities, Water Treatment Plants, Hospitality Sector
- By Service Type: On-site Testing, Laboratory Testing, Remote Monitoring Services
- By Application: Routine Surveillance, Outbreak Investigation, Regulatory Compliance Testing, Research and Development
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Culture Method leads By Testing Method at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Environmental Legionella Pneumophila Testing Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Testing Method 5
Sample Type 4
End-User 5
Service Type 3
Application 4
Companies profiled
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA (MilliporeSigma)
Hach Company (Danaher Corporation)
Charles River Laboratories
Eurofins Scientific
SGS SA
Bureau Veritas
ALS Limited
Intertek Group plc
3M Company
Neogen Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Hach Company (Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Charles River Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →SGS SA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Bureau Veritas
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ALS Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Intertek Group plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →3M Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Neogen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Micropathology Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Microbiology International Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LuminUltra Technologies Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,680M by 2033 · 10.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Culture Method49.3
- Polymerase Chain Reaction (PCR)8.6
- Immunofluorescence Assay (IFA)17.6
- Enzyme-Linked Immunosorbent Assay (ELISA)9.5
- Direct Fluorescent Antibody (DFA)15.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$714.1M → $1,539M · 10.1%
Europe$497.7M → $1,089M · 10.3%
Asia Pacific$454.4M → $1,027M · 10.7%
Latin America$281.3M → $548.9M · 8.7%
Middle East and Africa$216.4M → $453.6M · 9.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.082026
10.082027
10.102028
10.102029
10.132030
10.142031
10.162032
10.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific16.6
- Bio-Rad Laboratories15.2
- Merck KGaA (MilliporeSigma)8.8
- Hach Company (Danaher Corporation)13.5
- Charles River Laboratories7.7
- Eurofins Scientific10.1
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Testing Method25.6%
Sample Type8.7%
End-User21.1%
Service Type21.5%
Application23.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe23.4
- Asia Pacific22.1
- Latin America11.8
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 87 | 88 | 98 | 91 | 84 | 89 | 90 |
| Bio-Rad Laboratories | 70 | 79 | 73 | 79 | 90 | 90 | 80 |
| Merck KGaA (MilliporeSigma) | 85 | 82 | 84 | 63 | 75 | 84 | 79 |
| Hach Company (Danaher Corporation) | 57 | 72 | 79 | 58 | 59 | 69 | 66 |
| Charles River Laboratories | 52 | 54 | 63 | 52 | 64 | 55 | 57 |
| Eurofins Scientific | 56 | 58 | 61 | 53 | 50 | 52 | 55 |
| SGS SA | 49 | 58 | 45 | 59 | 41 | 46 | 50 |
| Bureau Veritas | 54 | 51 | 50 | 59 | 50 | 52 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Merck KGaA (MilliporeSigma)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Bio-Rad Laboratories | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Merck KGaA (MilliporeSigma) | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Hach Company (Danaher Corporation) | ◐ | ✓ | ◐ | − | ◐ | − |
| Charles River Laboratories | ◐ | − | − | − | ✓ | − |
| Eurofins Scientific | − | ◐ | − | − | − | ◐ |
| SGS SA | ◐ | ◐ | ◐ | ◐ | − | − |
| Bureau Veritas | ◐ | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific90
2Bio-Rad Laboratories80
3Merck KGaA (MilliporeSigma)79
4Hach Company (Danaher Corporation)66
5Charles River Laboratories57
6Eurofins Scientific55
7Bureau Veritas53
8SGS SA50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)
Contender2
Focused players with pockets of strength.
Hach Company (Danaher Corporation)Charles River Laboratories
Niche3
Specialists in a single segment or region.
Eurofins ScientificSGS SABureau Veritas
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Testing Method in North America, then scale across Environmental Legionella Pneumophila Testing Market — a $536M beachhead inside a $8.45B market.
Beachhead (SOM)$536Mobtainable near-term
Serviceable (SAM)$3.14Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Culture Method
Best fit — highest urgency & budget in Testing Method.
Economic buyer78 fit
Polymerase Chain Reaction (PCR)
Strong fit — clear ROI and a fast path to value.
End user68 fit
Immunofluorescence Assay (IFA)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Testing Method in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Sample Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel25%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Testing Method leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Environmental Legionella Pneumophila Testing Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified22%
Evaluation11%
Closed-won7%
$17.6KCAC
$86KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Environmental Legionella Pneumophila Testing Market is a durable-growth opportunity — $6.51B by 2033, compounding at 8.6%.
TAM · 2025$3.36Btoday
TAM · 2033$6.51Bforecast
CAGR8.6%2027–2033
Cumulative$43.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.51BTotal addressable market
SAM$2.53BServiceable available market
SOM$451MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Testing Method.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Testing Method moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.51BLarge & growingTAM by 2033 at 8.6% CAGR
$2.53BServiceable nowreachable with today’s model
$451MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.08BBear5.6% CAGR
$6.51BBase8.6% CAGR
$8.33BBull11.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Sample Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Environmental Legionella Pneumophila Testing Market — a $2.17B market by 2033. Plan: grow share from 11.3% to 18.4%.
Market size · 2033$2.17Btotal addressable
Market CAGR3.7%2027–2033
Target share18.4%from 11.3% today
Revenue ambition$400Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.3% | 18.4% | Behind |
| Revenue | $258M | $400M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.8% | 39.0% | At risk |
| Customer retention | 90.1% | 93.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Testing Method
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Sample Type capability
A defensible second engine — invest in Sample Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Testing Method share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Sample Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $59M capacity & capability investment
- Greenlight bolt-on M&A in Sample Type
- Authorise North America expansion plan
- Fund R&D program for Testing Method leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Environmental Legionella Pneumophila Testing Market conversation — a $6.73B market you can size, segment and defend in minutes.
Market size · 2033$6.73Btotal opportunity
Growth5.9%CAGR to 2033
Addressable buyers1,028+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Testing Method
Goal Grow share in Testing Method
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 3 mopayback period
$70K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)Hach Company (Danaher Corporation)Charles River LaboratoriesEurofins ScientificSGS SABureau Veritas+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Environmental Legionella Pneumophila Testing Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Environmental Legionella Pneumophila Testing Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Environmental and Sustainability · scroll →Environmental IoT Sensors Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportEnvironmental IoT Sensor Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportEnvironmental Intelligence Suite Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportEnvironmental Intelligence Solution Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportEnvironmental Intelligence Platform Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportEnvironmental Intelligence Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportEnvironmental Health and Safety Management Tools Market
Market size, share, segmentation and regional forecast.
$839M market · 2025 base year
View reportEnvironmental Health and Safety Management System Market
Market size, share, segmentation and regional forecast.
$541M market · 2025 base year
View reportEnvironmental Health and Safety (EHS) Software Market
Market size, share, segmentation and regional forecast.
$575M market · 2025 base year
View reportEnvironmental, Health and Safety (EHS) Compliance Service Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportEnvironmental Grease Cleaner Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportEnvironmental Forensics Expert Witness Service Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.